
Keywords: براون نروژ; corneal transplantation; graft rejection; ranibizumab; skin graft; vascular endothelial growth factor antibody; BN; Brown Norway; FGF; fibroblast growth factor; IL; interleukin; MMPs; matrix metalloproteinases; PDGF; platelet-derived growth factor; SD; Sp